ASM International NV (ASM)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 709.20 |
|---|---|
| 52-week range | 459.70 – 1,092.50 |
| Return, 1 month / 3 months | −17.6% / −20.8% |
| Return, 1 year / 3 years | +33.3% / +99.8% |
| Trend | Below its 200-day average |
| RSI (14) | 31 |
| Volatility (1 year) | 49.3% |
| Worst drawdown (1 year) | -34.3% |
| Average daily value traded | 122.16M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ASM International NV designs and builds equipment used to make semiconductors. Its main products are deposition systems, including atomic layer deposition and epitaxy tools, that place extremely thin layers of material onto silicon wafers. Chipmakers and semiconductor manufacturers around the world use these machines in the production of advanced logic, memory and other devices. The company is based in the Netherlands and supplies customers across the global semiconductor industry.
The shares are listed on the Euronext Amsterdam in Netherlands under the code ASM, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ASM International NV (ASM) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 709.20 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 73 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.3% and over the last three months it fell 20.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.5% | ||
| From 52-week high | -34.3% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.8% | ||
| 6-month return | -15.0% | ||
| 12-month return, skipping the last month | 61.8% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.3% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 122.16M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 28 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −7.4% |
|---|---|
| 1 month | −17.6% |
| 3 months | −20.8% |
| 6 months | −15.0% |
| 1 year | +33.3% |
| 3 years | +99.8% |
| 5 years | +107.1% |
Signals
| 50-day / 200-day average | 831.58 / 810.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 36.01 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 May 2026 | EUR 3.2500 |
| 14 May 2025 | EUR 3.0000 |
| 15 May 2024 | EUR 2.7500 |
| 17 May 2023 | EUR 2.5000 |
| 18 May 2022 | EUR 2.5000 |
| 19 May 2021 | EUR 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.